Předměty
Publikace
- Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry2017 | 1. lékařská fakulta
- Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study2017 | Publikace bez příslušnosti k fakultě
- Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy2016 | Publikace bez příslušnosti k fakultě
- Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry2015 | 1. lékařská fakulta
- Comparison of Two Prognostic Models in Patients with Metastatic Renal Cancer Treated with Sunitinib: a Retrospective, Registry-Based Study2015 | 1. lékařská fakulta
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma2015 | Publikace bez příslušnosti k fakultě
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial2014 | 2. lékařská fakulta
- Avastin v 1. linii léčby metastatického karcinomu prsu - naše zkušenosti: kazuistika2013 | 2. lékařská fakulta
- Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial2012 | 2. lékařská fakulta
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen2012 | 2. lékařská fakulta
Loading network view...
